Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2

Journal of Neural Transmission

Volumn 114, Issue 4, 2007, Pages 427-430

  Schwartz, K ^a   Nachman, R ^a   Yossifoff, M ^a   Sapir, R ^a   Weizman, A ^a   Rehavi, M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amphetamine; Cocaine; Prefrontal cortex; Striatum; Vesicular monoamine transporter 2 (VMAT2)

Indexed keywords

AMPHETAMINE; COCAINE; DIHYDROTETRABENAZINE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

AMPHETAMINE; ANIMALS; BRAIN; COCAINE; DOPAMINE AGENTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 33947496041     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0549-8     Document Type: Article

References (14)

1. JM Brown GR Hanson AE Fleckenstein 2000 Methamphetamine rapidly decreases vesicular dopamine uptake J Neurochem 74 2221 2223
2. G Di Chiara A Imperato 1988 Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci USA 85 5274 5278
3. K Frey M Kilbourn T Robinson 1997 Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine Eur J Pharmacol 334 273 279
4. KA Hogan RG Staal PK Sonsalla 2000 Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations J Neurochem 74 2217 2220
5. KY Little DM Krolewski L Zhang BJ Cassin 2003 Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users Am J Psychiatry 160 47 55
6. EL Riddle MK Topham JW Haycock GR Hanson AE Fleckenstein 2002 Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine Eur J Pharmacol 449 71 74
7. G Rudnick SC Wall 1992 The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc Natl Acad Sci USA 89 1817 1821
8. S Schuldiner 1994 A molecular glimpse of vesicular monoamine transporters J Neurochem 62 2067 2078
9. S Schuldiner S Steiner-Mordoch R Yelin SC Wall G Rudnick 1993 Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters Mol Pharmacol 44 1227 1231
10. Schwartz K, Weizman A, Rehavi M (2005) The effect of psychostimulants on [(3)H]dopamine uptake and release in rat brain synaptic vesicles. J Neural Transm [Epub ahead of print]
11. JK Staley JZ Talbot BJ Ciliax GW Miller AI Levey MP Kung 1997 Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims Brain Res 747 219 229
12. D Sulzer S Rayport 1990 Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action Neuron 5 797 808
13. JM Wilson SJ Kish 1996 The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat J Neurosci 16 3507 3510
14. JM Wilson AI Levey C Bergeron K Kalasinsky L Ang F Peretti 1996 Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users Ann Neurol 40 428 439